Atlas Trials

Dimethyl Fumarate in Adrenomyeloneuropathy

Clinical trial NCT06513533 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06513533
Sponsor
Pujol, Aurora, M.D.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Adrenomyeloneuropathy Without Cerebral Involvement
Start date
2024-04-23
Primary completion
2028-03-31
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.